Biosimilars Must Play Key Role In EU Pharma Strategy

Medicines For Europe Welcomes Latest Annual Report On Competition

 
• By Dave Wallace
  
Europe
European policy makers must act quickly to harness the benefits of biosimilars • Source: Shutterstock

More from Policy & Regulation

More from Generics Bulletin